Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - rifampicin, quantity: 20 mg/ml - oral liquid - excipient ingredients: agar; sucrose; methyl hydroxybenzoate; propyl hydroxybenzoate; potassium sorbate; saccharin; polysorbate 80; diethanolamine; purified water; sodium metabisulfite; fragrance (perfume) - tuberculosis. in the initial treatment and in re-treatment of patients with tuberculosis, rifadin must be used in conjunction with at least one other antituberculosis drug. leprosy. in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the noninfectious state, which may be expected to occur in 3 to 4 months of treatment. as an alterantive drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other antileprosy drugs. as an alternative drug in all those patients having true drug allergy to the more commonly used antileprosy drugs. meningococcal disease. prophylaxis of meningococcal disease in close contacts of known cases and in carriers. (rifadin is not indicated for the treatment of meningococcal infections). haemophilus influenzae. prophylaxis of household contacts of patients with h. influenzae type b.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - praziquantel 600mg - film coated tablet - 600 mg - active: praziquantel 600mg excipient: hypromellose macrogol 4000 magnesium stearate maize starch microcrystalline cellulose povidone purified water   sodium laurilsulfate titanium dioxide - treatment of schistosoma infections due to various types of blood fluke (e.g. schistosoma haematobium, s. japonicum, s. mekongi or s mansoni).

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - darunavir ethanolate 650.46mg equivalent to darunavir 600 mg - film coated tablet - 600 mg - active: darunavir ethanolate 650.46mg equivalent to darunavir 600 mg excipient: crospovidone magnesium stearate opadry orange 85f13962 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - efavirenz 600mg - film coated tablet - 600 mg - active: efavirenz 600mg excipient: carnauba wax croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 03b12896 purified water   sodium laurilsulfate - stocrin is indicated in antiviral combination treatment of hiv-1 infected adults, adolescents and children

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - oxcarbazepine 600mg;  ;  ;   - film coated tablet - 600 mg - active: oxcarbazepine 600mg       excipient: colloidal silicon dioxide crospovidone hypromellose   iron oxide black iron oxide red macrogol 4000 magnesium stearate powdered cellulose purified talc titanium dioxide - trileptal is indicated in adults and children aged 1 month and above for the treatment of · partial seizures (which include the seizure subtypes of simple, complex and partial seizures evolving to secondarily generalised seizures) and · generalised tonic-clonic seizures. trileptal is indicated as a first-line antiepileptic drug for use as monotherapy or adjunctive therapy. trileptal can replace other antiepileptic drugs when current therapy provides insufficient seizure control.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - linezolid 600mg;  ; linezolid 600mg - film coated tablet - 600 mg - active: linezolid 600mg   excipient: carnauba wax hyprolose magnesium stearate maize starch opacode red s-1-5066 opadry white ys-1-18202 powdered cellulose sodium starch glycolate active: linezolid 600mg excipient: carnauba wax hyprolose magnesium stearate maize starch opacode red s-1-15118 opadry white ys-1-18202 powdered cellulose sodium starch glycolate - zyvox is indicated for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: · pneumonia - community acquired and nosocomial pneumonia · skin and soft tissue infections · enterococcal infections. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected. consideration should be given to official guidance on the appropriate use of antibacterial agents.

Philippines - English - FDA (Food And Drug Administration)

am-europharma corp - rifampicin - capsule - 450mg

Philippines - English - FDA (Food And Drug Administration)

compact pharmaceutical corporation - rifampicin - capsule - 450mg

Philippines - English - FDA (Food And Drug Administration)

j.m. tolmann labs inc - rifampicin , isoniazid - tablet, film coated - 150mg + 75mg

Philippines - English - FDA (Food And Drug Administration)

j.m. tolmann labs., inc - rifampicin , isoniazid , pyrodoxine hydrochloride (vit b6) - suspension, oral - 60mg + 30mg + 25mg